Patent details

Basic Information

Publication number:

EP1663287

PCT Application Number:

PCT/EP/2004/009804

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047647623

PCT Publication Number:

WO/2005/021028

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF MODIFIED CYCLOSPORINS FOR THE TREATMENT OF HCV DISORDERS

French Title of Invention:

UTILISATION DE CYCLOSPORINES POUR LE TRAITEMENT DES TROUBLES LIES AU VHC

German Title of Invention:

VERWENDUNG VON MODIFIZIERTEN CYCLOSPORINEN ZUR BEHANDLUNG VON HCV-ERKRANKUNGEN

SPC Number:

Dates

Filing date:

02/09/2004

Grant date:

15/07/2009

EP Publication Date:

15/07/2009

PCT Publication Date:

10/03/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2006

EP B1 Publication Date:

15/07/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/09/2020

Expiration date:

02/09/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/09/2004

 

 

Name:

NOVARTIS AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

SHIMOTOHNO Kunitada, Fushimi Godosyukusya 245

Address:

Japan (JP)

2

Name:

WATASHI Koichi, Ichijo-heights 203

Address:

Japan (JP)

3

Name:

HIJIKATA Makoto, Fujinomori Godoshukusha 217

Address:

Japan (JP)

Priority

Priority Number:

0320638

Priority Date:

03/09/2003

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 38/13;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/08/2019

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages